Chow W H, Gridley G, Fraumeni J F, Järvholm B
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892-7240, USA.
N Engl J Med. 2000 Nov 2;343(18):1305-11. doi: 10.1056/NEJM200011023431804.
Obesity and hypertension have been implicated as risk factors for the development of renal-cell cancer.
We examined the health records of 363,992 Swedish men who underwent at least one physical examination from 1971 to 1992 and were followed until death or the end of 1995. Men with cancer (renal-cell cancer in 759 and renal-pelvis cancer in 136) were identified by cross-linkage of data with the nationwide Swedish Cancer Registry. Poisson regression analysis was used to estimate relative risks, with adjustments for age, smoking status, body-mass index, and diastolic blood pressure.
As compared with men in the lowest three eighths of the cohort for body-mass index, men in the middle three eighths had a 30 to 60 percent greater risk of renal-cell cancer, and men in the highest two eighths had nearly double the risk (P for trend, <0.001). There was also a direct association between higher blood pressures and a higher risk of renal-cell cancer (P for trend, <0.001 for diastolic pressure; P for trend, 0.007 for systolic pressure). After the first five years of follow-up had been excluded to reduce possible effects of preclinical disease, the risk of renal-cell cancer was still consistently higher in men with a higher body-mass index or higher blood pressure. At the sixth-year follow-up, the risk rose further with increasing blood pressures and decreased with decreasing blood pressures, after adjustment for base-line measurements. Men who were current or former smokers had a greater risk of both renal-cell cancer and renal-pelvis cancer than men who were not smokers. There was no relation between body-mass index or blood pressure and the risk of renal-pelvis cancer.
Higher body-mass index and elevated blood pressure independently increase the long-term risk of renal-cell cancer in men. A reduction in blood pressure lowers the risk.
肥胖和高血压被认为是肾细胞癌发生的危险因素。
我们检查了363992名瑞典男性的健康记录,这些男性在1971年至1992年期间至少接受过一次体检,并一直随访至死亡或1995年底。通过将数据与瑞典全国癌症登记处进行交叉关联,确定患有癌症的男性(759例肾细胞癌和136例肾盂癌)。采用泊松回归分析来估计相对风险,并对年龄、吸烟状况、体重指数和舒张压进行了调整。
与体重指数处于队列中最低八分之三的男性相比,处于中间八分之三的男性患肾细胞癌的风险高30%至60%,而处于最高八分之二的男性患肾细胞癌的风险几乎翻倍(趋势P值<0.001)。血压升高与肾细胞癌风险增加之间也存在直接关联(舒张压趋势P值<0.001;收缩压趋势P值0.007)。为减少临床前疾病的可能影响,排除随访的前五年后,体重指数较高或血压较高的男性患肾细胞癌的风险仍然持续较高。在第六年随访时,经基线测量调整后,随着血压升高风险进一步上升,随着血压降低风险下降。目前或曾经吸烟的男性患肾细胞癌和肾盂癌的风险均高于不吸烟的男性。体重指数或血压与肾盂癌风险之间无关联。
较高的体重指数和血压升高独立增加男性患肾细胞癌的长期风险。降低血压可降低风险。